
Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Ge51-200 Employees
- B2B
- Scale StageRapidly increasing operations
- Top InvestorsThis company has received a significant amount of investment from top investors
Deep Genomics Funding
$56.7M
33 rounds
Deep Genomics is active in the following markets / industries: biotechnology, artificial intelligence, therapeutics and genetic testing. The company has secured funding across 3 rounds, totaling in an amount of $56.7M. Their most recent funding was raised on January 7, 2020.
Funding Rounds
B
$40000000A
$13000000S
$3700000Investors of Deep Genomics
Khosla Ventures
We fundamentally like large problems that are amenable to technology solutions
Rounds
A
True Ventures
Rounds
S
Bloomberg Beta
Early-stage venture fund backed by Bloomberg that invests in startups making work better
Rounds
S
Richard Hyatt
Co-Founder BlueCat Networks and Dyadem
11.2 Capital